From: Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings
Vaccine
n = 49
n (%)
Control
n = 40
P-value
HPV-16
< 0.001
Positive
31 (63.3)
5 (12.5)
Borderline
14 (28.6)
2 (5.0)
HPV-18
0.042
17 (34.7)
8 (20.0)
5 (10.2)